[…]
eNews May 2022

The Foundation for Peripheral Neuropathy is pleased to announce that peripheral neuropathy has been renewed as an eligible condition for Department of Defense (DOD) funds for the upcoming year. The Bill recently made it into law and FPN is proud that its lobbying campaign this past year was a success! Peer-Reviewed Medical Research Program The […]
The Department of Defense’s (DoD) Peer-Reviewed Medical Research Program (PRMRP) has determined the grant applications that it wishes to award in fiscal year 2021 (FY21). In this first year that applications were accepted for research in peripheral neuropathy, 41 applications out of over 1000 applications received focused on peripheral neuropathy. DoD is recommending awarding a grant […]
A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. […]
Read More… from AAN’s New Painful Diabetic Polyneuropathy Guidelines
Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels […]
Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to […]